References
- Al-Amin, M.D., et al., 2020. Dexamethasone loaded liposomes by thin-film hydration and microfluidic procedures: formulation challenges. International journal of molecular sciences, 21 (5), 1611.
- Ali, I., et al., 2020. Synthesis of long-tail nonionic surfactants and their investigation for vesicle formation, drug entrapment, and biocompatibility. Journal of liposome research, 30 (3), 255–262.
- Avsievich, T., et al., 2019. Impact of nanocapsules on red blood cells interplay jointly assessed by optical tweezers and microscopy. Micromachines, 11 (1), 19.
- Ballas, S.K., and Smith, E.D., 1992. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood, 79 (8), 2154–2163.
- Bensikaddour, H., et al., 2008. Interactions of ciprofloxacin with DPPC and DPPG: fluorescence anisotropy, ATR-FTIR and 31P NMR spectroscopies and conformational analysis. Biochimica et Biophysica Acta (BBA) – Biomembranes, 1778 (11), 2535–2543.
- Brugnara, C., 1995. Red cell dehydration in pathophysiology and treatment of sickle cell disease. Current opinion in hematology, 2 (2), 132–138.
- Bunn, H.F., 1997. Pathogenesis and treatment of sickle cell disease. New England journal of medicine, 337 (11), 762–769.
- Cakmak Arslan, G. and Severcan, F., 2019. The effects of radioprotectant and potential antioxidant agent amifostine on the structure and dynamics of DPPC and DPPG liposomes. BBA – biomembranes, 1861, 1240–1251.
- Castan, L., et al., 2013. Biological activity of liposomal Vanillin. Journal of medicinal food, 16 (6), 551–557.
- Charache, S., et al., 1995. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. New England journal of medicine, 332 (20), 1317–1322.
- Costa, L.L., et al., 2016. Glutamine-loaded liposomes: preliminary investigation, characterization and evaluation of neutrophil viability. AAPS PharmSciTech, 17 (2), 446–453.
- De Franceschi, L., 2009. Pathophisiology of sickle cell disease and new drugs for the treatment. Mediterranean journal of hematology and infectious diseases, 1 (1), e2009024.
- Dicko, A., et al., 1999. Effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluor- escence spectroscopy. Brain research bulletin, 49, 401–405.
- Eaton, W.A., and Hofrichter, J., 1990. Sickle cell hemoglobin polymerization. Advance protein chemistry, 40, 63–279.
- Embury, S.H., 1986. The clinical pathophysiology of sickle cell disease. Annual review of medicine, 37, 361–376.
- Er Öztaş, Y., 2010. The investigation of plasma and erythrocyte medium in sickle cell anemia by biochemical parameters. PhD Thesis. Hacettepe University.
- Fricker, G., et al., 2010. Phospholipids and lipid-based formulations in oral drug delivery. Pharmaceutical research, 27 (8), 1469–1486.
- Fritzsching, K.J., Kim, J., and Holland, G.P., 2013. Probing lipid–cholesterol interactions in DOPC/eSM/Chol and DOPC/DPPC/Chol model lipid rafts with DSC and 13C solid-state NMR. Biochimica et Biophysica Acta, 1828, 1889–1898.
- Gardner, R.V., 2018. Sickle cell disease: advances in treatment. Ochsner journal, 18 (4), 377–389.
- Gibson, X.A., et al., 1998. The efficacy of reducing agents or antioxidants in blocking the formation of dense cells and irreversibly sickled cells in vitro. Blood, 91 (11), 4373–4378.
- Guan, P., et al., 2011. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. International journal of nanomedicine, 6, 965–974.
- Hebbel, R.P., 1991. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood, 77 (2), 214–237.
- Henriksen, I., et al., 1995. In vitro evaluation of drug release kinetics from liposomes by fractional dialysis. International journal of pharmaceutics, 119, 231–238.
- Himeno, H., et al., 2014. Charge-induced phase separation in lipid membranes. Soft Matter, 10 (40), 7959–7967.
- Iannone, R., et al., 2005. Bone marrow transplantation for sickle cell anemia: progress and prospects. Pediatric blood & cancer, 44 (5), 436–440.
- Irie, T., Watarai, S., Kodama, H., 2003. Humoral immune response of carp (Cyprinus carpio) induced by oral immunization with liposome- entrapped antigen. Developmental and comparative immunology, 27 (5), 413–421.
- Kumpati, J., 1982. Inhibition of sickling by liposome-mediated transport of amino acids into intact human red blood cells. Biochemical and biophysical research communications, 105 (2), 482–487.
- Kumpati, J., 1987. Liposome-loaded phenylalanine or tryptophan as sickling inhibitor: a possible therapy for sickle cell disease. Biochemical medicine and metabolic biology, 38 (2), 170–181.
- Li, Q., Li, X., and Zhao, C., 2020. Strategies to obtain encapsulation and controlled release of small hydrophilic molecules. Frontiers in bioengineering and biotechnology, 8, 437.
- Liu, Y., et al., 2012. Formulation and characterization of boanmycin-loaded liposomes prepared by pH gradient experimental design. Drug delivery, 19 (2), 90–101.
- Lobitz, S., et al., 2018. Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference. British journal of haematology, 183 (4), 648–660.
- Mady, M.M., et al., 2012. Biophysical characterization of gold nanoparticles-loaded liposomes. Physica Medica, 28, 288–295.
- Manrique-Moreno, M., et al., 2016. Biophysical study of the non-steroidal anti-inflammatory drugs (NSAID) ibuprofen, naproxen and diclofenac with phosphatidylserine bilayer membranes. Biochimica et Biophysica Acta, 1858, 2123–2131.
- Masarudin, M.J., et al., 2015. Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]- doxorubicin. Nanotechnology, science and applications, 8, 67–80.
- Mishra, B., et al., 2011. Lipid-based oral multiparticulate formulations – advantages, technological advances and industrial applications. Expert opinion on drug delivery, 8 (2), 207–224.
- Moen, M.D., Lyseng-Williamson, K.A., and Scott, L.J., 2009. Liposomal amphotericin BP a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs, 69 (3), 361–392.
- Nagalla, S., and Ballas, S.K., 2016. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Department of medicine faculty papers, 154.
- Najlah, M., et al., 2015. A facile approach to manufacturing non-ionic surfactant nanodipsersions using proniosome technology and high-pressure homogenization. Journal of liposome research, 25 (1), 32–37.
- Najlah, M., et al., 2019. Development of injectable PEGylated liposome encapsulating disulfiram for colorectal cancer treatment. Pharmaceutics, 11 (11), 610.
- Ndefo, U.A., et al., 2008. Pharmacological management of sickle cell disease. Pharmacy and therapeutics, 33 (4), 238–243.
- Nevitt, S.J., Jones, A.P., and Howard, J., 2017. Hydroxyurea (hydroxycarbamide) for sickle cell disease. Cochrane database of systematic reviews, (4), CD002202.
- Niu, M.M., et al., 2011. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. International journal of nanomedicine 6, 1155–1166.
- Nounou, M.I., et al., 2006. In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels. Acta Pharmaceutica, 56 (3), 311–324.
- Panwar, P., et al., 2010. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. International journal of nanomedicine, 5, 101–108.
- Paveli, Z., Kalko Basnet, N., and Schubert, R., 2001. Liposomal gels for vaginal drug delivery. International journal of pharmaceutics, 219, 139–149.
- Pawlukojc, A., et al., 2014. L-glutamine: Dynamical properties investigation by means of INS, IR, RAMAN, 1H NMR and DFT techniques. Chemical physics, 443, 17–25.
- Quinn, C.T., 2013. Sickle Cell Disease in Childhood: From Newborn Screening Through Transition to Adult Medical Care. Pediatric clinics of North America, 60 (6), 1363–1381.
- Refai, H., Hassan, D., and Abdelmonem, R., 2017. Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate. Drug delivery, 24 (1), 278–288.
- Rhys, N.H., Soper, A.K., and Dougan, L., 2012. The hydrogen-bonding ability of the amino acid glutamine revealed by neutron diffraction experiments. The journal of physical chemistry B, 116 (45), 13308–13319.
- Sariisik, E., et al., 2019. Interaction of the cholesterol reducing agent simvastatin with zwitterionic DPPC and charged DPPG phospholipid membranes. BBA – biomembranes, 1861, 810–818.
- Saunthararajah, Y., et al., 2008. Clinical effectiveness of decitabine in severe sickle cell disease. British journal of haematology, 141 (1), 126–129.
- Schwartz, R.S., et al., 1983. Interaction of phosphatidylserine-phosphatidylcholine liposomes with sickle erythrocytes. Journal of clinical investigation, 71 (6), 1570–1580.
- Sciolla, F., et al., 2021. Influence of drug/lipid interaction on the entrapment efficiency of isoniazid in liposomes for antitubercular therapy: a multi-faced investigation. preprint.
- Steinberg, M.H., 1999. Management of sickle cell disease. New England journal of medicine, 340 (13), 1021–1030.
- Steinberg, M.H., et al., 2003. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA, 289 (13), 1645–1651.
- Teong, B., et al., 2014. Characterization and human osteoblastic proliferation- and differentiation-stimulatory effects of phosphatidylcholine liposomes-encapsulated propranolol hydrochloride. Bio-medical materials and engineering, 24, 1875–1887.
- Toyran, N. and Severcan, F., 2003. Competitive effect of vitamin D and Ca on phospholipid model membranes: an FTIR study. Chemistry and physics of lipids, 123, 165–176.
- Yang, E., et al., 2018. Microfluidic preparation of liposomes using ethyl acetate/n-hexane solvents as an alternative to chloroform. Journal of chemistry, 2018, 1–6.
- Zasadzinski, J.A., et al., 2011. Novel methods of enhanced retention in and rapid, targeted release from liposomes. Current opinion in colloid and interface science, 16 (3), 203–214.
- Zhang, L., et al., 2016. Long circulating anionic liposomes for hepatic targeted delivery of cisplatin. RSC Advances, 6, 76905–76914.